Greenway Medical merger:
Greenway Medical Technologies, Inc. (NYSE:GWAY
) recently entered into a merger agreement, according to a filing from one of its shareholders, Pamlico Capital, which holds 17.8% of its shares. Under the terms of the agreement VCG Holdings and Crestview Acquisition Corp will purchase all of the outstanding shares of Greenway Medical Technologies for a price of $20.35 per share.
Pamlico Capital owns 5.3 million shares of Greenway Medical Technologies, with the value of the stake amounting to $107.8 million. For its fiscal year ended June 30, Greenway Medical reported a net loss of $5.1 million, versus an income of $2.9 million in the previous fiscal year. For FY2014, the company forecasted a net loss between $6.3 million and $5 million, Greenway said in a statement.
In addition to Pamlico, some hedge funds also disclosed ownership of Greenway Medical Technologies in the latest round of 13F filings. As follows, CR Intrinsic Investors
, an SAC Capital Subsidiary, owned 307,300 shares, followed by Chuck Royce's Royce & Associates
with 150,000 shares, and D. E. Shaw's D. E .Shaw & Co
. Check back here for more updates on the Greenway Medical merger.
Hedge Fund News: Carl Icahn, Bill Ackman & Man Group’s Sell Ratings
The Scoop on Bill Ackman’s Air Products & Chemicals Bombshell
Is RTI Surgical a Good Buy? The Newly-Formed Hedge Fund Thinks So